Powin Biomedical Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Challenges
Economic Losses:
The COVID-19 pandemic has caused significant economic losses exceeding 20 trillion USD globally.
Vaccine Hesitancy:
Despite the introduction of mRNA vaccines, vaccine hesitancy among the public continues to persist.
Evolvin
Economic Losses:
The COVID-19 pandemic has caused significant economic losses exceeding 20 trillion USD globally.
Vaccine Hesitancy:
Despite the introduction of mRNA vaccines, vaccine hesitancy among the public continues to persist.
Evolvin
The content above was translated by Ai
Founded Year
2021
Unified Business No.
91044533
Status
Active
Number of Employees
0
Total Paid-in
Capital
40,500,000 (NT$)
Location of Company
Taiwan
, Taichung City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Intelligene stands as one of the pioneering drug development companies in Taiwan's biotechnology sector. We are at the forefront of advancing gene therapeutics through siRNA-based drugs, utilizing a revolutionary approach that harnesses the power of RNA i
The content above was translated by Ai
